Washington Trust Bank Biogen Inc. Transaction History

Washington Trust Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 29, 2019	SELL	$217.44 - $243.88 $209,829 - $235,344	-965 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$219.29 - $241.72 $39,691 - $43,751	-181 Reduced 15.79%	965 $226,000
Q1 2019 Apr 09, 2019	BUY	$216.71 - $338.96 $23,838 - $37,285	110 Added 10.62%	1,146 $271,000
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $34,812 - $44,093	-125 Reduced 10.77%	1,036 $312,000
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $372,757 - $487,464	-1,270 Reduced 52.24%	1,161 $411,000
Q1 2018 Apr 03, 2018	SELL	$260.13 - $367.91 $26,013 - $36,791	-100 Reduced 3.95%	2,431 $666,000
Q3 2017 Oct 05, 2017	BUY	$281.15 - $329.69 $711,590 - $834,445	2,531	2,531 $793,000

996

130M

1.57M

2.25M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $19.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Washington Trust Bank, based on Form 13F filings with the SEC.

Stay updated on Washington Trust Bank with notifications on news.